Ocuphire Pharma, Inc.·4

Jan 22, 6:01 PM ET

Hoffmann Bernhard 4

4 · Ocuphire Pharma, Inc. · Filed Jan 22, 2024

Insider Transaction Report

Form 4
Period: 2024-01-18
Hoffmann Bernhard
SVP of Corp. Dev.
Transactions
  • Award

    Common Stock

    2024-01-18+20,000162,697 total
  • Award

    Employee Stock Option (right to buy)

    2024-01-18+30,00030,000 total
    Exercise: $2.77Exp: 2034-01-17Common Stock (30,000 underlying)
Footnotes (2)
  • [F1]Represents a grant of restricted stock units which vest in four equal installments on the first, second, third and fourth anniversary of the grant date of January 18, 2024.
  • [F2]The option will vest with respect to 7,500 shares on January 18, 2025, with the balance vesting quarterly in twelve equal installments thereafter at the end of each quarter.

Documents

1 file
  • 4
    form4.xmlPrimary

    FORM 4